Rituximab and risk of infections in patients with pemphigus: answers from a global population-based cohort study

Br J Dermatol. 2023 Mar 30;188(4):454-455. doi: 10.1093/bjd/ljad005.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Azathioprine
  • Cohort Studies
  • Humans
  • Mycophenolic Acid
  • Pemphigus* / drug therapy
  • Pemphigus* / epidemiology
  • Rituximab / adverse effects
  • Treatment Outcome

Substances

  • Rituximab
  • Azathioprine
  • Mycophenolic Acid